Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anson Snow

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Therapeutic Advances in Hematology|July 28, 2022
The development of pevonedistat in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML): hope or hype?Anson Snow, Joshua F Zeidner
BMJ Case Reports|June 23, 2019
Two synchronous malignancies: nodular melanoma and renal cell carcinoma in a patient with an underlying germline <i>BRCA2</i> mutationAnson Snow, Charite Ricker, Gino K In
Expert Review of Molecular Diagnostics|September 5, 2019
The current status of the clinical utility of liquid biopsies in cancerAnson Snow, Denaly Chen, Julie E Lang
Chemico-Biological Interactions|December 3, 2014
Aldose reductase inhibition alleviates hyperglycemic effects on human retinal pigment epithelial cellsKun-Che Chang, Anson Snow, Daniel V LaBarbera, et al.
Cancer Epidemiology|November 29, 2020
Incidence of radiation induced sarcoma attributable to radiotherapy in adults: A retrospective cohort study in the SEER cancer registries across 17 primary tumor sitesAnson Snow, Alexander Ring, Lucas Struycken, et al.
Cancer Biology & Medicine|May 5, 2016
The potential for liquid biopsies in the precision medical treatment of breast cancerVictoria A Forte, Dany K Barrak, Mostafa Elhodaky, et al.
Chemico-Biological Interactions|December 27, 2014
Aldose reductase expression as a risk factor for cataractAnson Snow, Biehuoy Shieh, Kun-Che Chang, et al.
Journal of Medicinal Chemistry|December 18, 2013
Design of an amide N-glycoside derivative of β-glucogallin: a stable, potent, and specific inhibitor of aldose reductaseLinfeng Li, Kun-Che Chang, Yaming Zhou, et al.
Annals of Surgical Oncology|January 9, 2022
Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast CancerAlexander Ring, Daniel Campo, Tania B Porras, et al.
Leukemia & Lymphoma|November 2, 2022
A multi-center analysis of the impact of DA-EPOCH-R dose-adjustment on clinical outcomes of patients with double/triple-hit lymphomaMatthew J Cortese, Wei Wei, Sebastian Cerdeña, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Therapeutic Advances in Hematology|July 28, 2022
The development of pevonedistat in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML): hope or hype?Anson Snow, Joshua F Zeidner
BMJ Case Reports|June 23, 2019
Two synchronous malignancies: nodular melanoma and renal cell carcinoma in a patient with an underlying germline <i>BRCA2</i> mutationAnson Snow, Charite Ricker, Gino K In
Expert Review of Molecular Diagnostics|September 5, 2019
The current status of the clinical utility of liquid biopsies in cancerAnson Snow, Denaly Chen, Julie E Lang
Chemico-Biological Interactions|December 3, 2014
Aldose reductase inhibition alleviates hyperglycemic effects on human retinal pigment epithelial cellsKun-Che Chang, Anson Snow, Daniel V LaBarbera, et al.
Cancer Epidemiology|November 29, 2020
Incidence of radiation induced sarcoma attributable to radiotherapy in adults: A retrospective cohort study in the SEER cancer registries across 17 primary tumor sitesAnson Snow, Alexander Ring, Lucas Struycken, et al.
Cancer Biology & Medicine|May 5, 2016
The potential for liquid biopsies in the precision medical treatment of breast cancerVictoria A Forte, Dany K Barrak, Mostafa Elhodaky, et al.
Chemico-Biological Interactions|December 27, 2014
Aldose reductase expression as a risk factor for cataractAnson Snow, Biehuoy Shieh, Kun-Che Chang, et al.
Journal of Medicinal Chemistry|December 18, 2013
Design of an amide N-glycoside derivative of β-glucogallin: a stable, potent, and specific inhibitor of aldose reductaseLinfeng Li, Kun-Che Chang, Yaming Zhou, et al.
Annals of Surgical Oncology|January 9, 2022
Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast CancerAlexander Ring, Daniel Campo, Tania B Porras, et al.
Leukemia & Lymphoma|November 2, 2022
A multi-center analysis of the impact of DA-EPOCH-R dose-adjustment on clinical outcomes of patients with double/triple-hit lymphomaMatthew J Cortese, Wei Wei, Sebastian Cerdeña, et al.
Pageof 2